Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
argenx SE - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ARGX
Nasdaq
2830
argenx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for argenx SE
Argenx Flops, As Viridian Celebrates, On Surprise Setback For Vyvgart Powerhouse
- Dec 15th, 2025 2:28 pm
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
- Dec 15th, 2025 9:08 am
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Data-Filled Week
- Dec 15th, 2025 7:02 am
Traders Eye Upcoming Economic Data as US Equity Futures Gain Pre-Bell
- Dec 15th, 2025 6:53 am
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
- Dec 14th, 2025 11:00 pm
Eli Lilly Leads Five Stocks Near Buy Points In Divided Market
- Dec 13th, 2025 6:00 am
KROS vs. ARGX: Which Stock Is the Better Value Option?
- Dec 12th, 2025 9:40 am
How Recent Developments Are Rewriting the Story for argenx Amid Analyst Optimism and Caution
- Dec 2nd, 2025 3:12 pm
European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
- Dec 2nd, 2025 9:11 am
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
- Dec 1st, 2025 9:02 am
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gain 4% for Week
- Nov 28th, 2025 9:11 am
Biotechs Are On A Big Run, And Two Stocks Have Buy Points
- Nov 28th, 2025 8:07 am
Are argenx Shares Still at a Discount After Clinical Trial Wins and 48% Rally?
- Nov 19th, 2025 8:13 am
Is Health Canada's Approval of VYVGART SC Transforming the Investment Case for argenx (ENXTBR:ARGX)?
- Nov 19th, 2025 1:14 am
argenx Announces Results of Extraordinary General Meeting of Shareholders
- Nov 18th, 2025 2:01 pm
Vera Therapeutics Stock Earns RS Rating Upgrade
- Nov 18th, 2025 12:19 pm
Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks
- Nov 17th, 2025 9:05 am
Here’s Why argenx SE (ARGX) Rose in Q3
- Nov 13th, 2025 5:58 am
Syndax Pharmaceuticals Stock Earns RS Rating Upgrade
- Nov 11th, 2025 11:04 am
Evaluating argenx (ENXTBR:ARGX): Does Market Momentum Reflect True Valuation?
- Nov 7th, 2025 7:12 am
Scroll